Orthostatic syncope is a transient loss of consciousness caused by cerebral hypoperfusion due to an abnormal drop in blood pressure upon assuming an upright posture. It is defined by a ≥20 mmHg systolic or ≥10 mmHg diastolic BP drop on standing and accounts for approximately 9% of all syncope presentations. [1-2] The prognosis is generally good compared to cardiac syncope, but it is associated with falls, injury, reduced quality of life, and increased mortality, particularly in older adults. [3]
The following algorithm from the 2017 ACC/AHA/HRS guidelines outlines the treatment approach for orthostatic hypotension as a cause of syncope:
1. History
- Positional relationship: Did the episode occur on standing from supine/sitting, after prolonged standing, or within a few steps of standing? Symptoms that occur only when upright and improve when seated or lying down are highly suggestive. [3][5]
- Prodrome: Lightheadedness, blurry/dimmed vision, muffled hearing, cognitive slowing, "tunnel vision," warmth, or diaphoresis preceding LOC [5]
- Timing and triggers: Morning episodes (post-overnight natriuresis), postprandial, post-exercise, hot environments, prolonged recumbency, alcohol intake, dehydration [5]
- "Coat hanger" pain: Aching in the neck/shoulders from hypoperfusion of trapezius muscles — highly specific for neurogenic orthostatic hypotension (nOH) [5]
- Duration of LOC: Typically brief (seconds); prolonged LOC or postictal state suggests alternative diagnosis
- Medication changes: Recent initiation, dose increase, or addition of antihypertensives, diuretics, vasodilators, alpha-blockers, dopaminergic agents, tricyclics, or opioids [3]
- Fluid/oral intake: Assess hydration status, recent illness with vomiting/diarrhea, poor oral intake
- Frequency and recurrence: Number of prior episodes, progressive worsening, associated injuries from falls
- Important negatives: No exertional syncope, no chest pain, no palpitations, no seizure activity, no focal neurologic deficits [1]
2. Alarm Features
- Syncope during exertion or while supine (suggests cardiac etiology) [1]
- Sudden onset palpitations or lack of prodrome [1]
- Associated chest pain or shortness of breath [1]
- Family history of sudden cardiac death or cardiomyopathy [6]
- Persistent bradycardia or new murmur [1]
- SBP <90 mmHg that does not correct with fluids [1]
- Focal neurologic deficits or prolonged altered mental status (suggests stroke, seizure, or head injury) [1]
- GI bleeding (melena, hematemesis, hematochezia) [1]
- Signs of pulmonary embolism (pleuritic chest pain, tachycardia, hypoxia) [1]
3. Medications
Common offenders causing/worsening orthostatic hypotension: [3]
- Antihypertensives (especially alpha-blockers, calcium channel blockers, ACE inhibitors, ARBs)
- Diuretics (loop, thiazide)
- Nitrates and vasodilators
- Dopaminergic agents (levodopa, dopamine agonists)
- Tricyclic antidepressants, MAOIs, SSRIs
- Antipsychotics (phenothiazines, atypical antipsychotics)
- Opioids, benzodiazepines
- PDE5 inhibitors (sildenafil, tadalafil)
Treatment medications: [3]
Contraindicated medications: Avoid initiating or escalating antihypertensives, diuretics, or vasodilators without reassessing orthostatic symptoms. Fludrocortisone is contraindicated in heart failure. [7]
4. Diet
- Acute: Rapid ingestion of 500 mL water (bolus water drinking) raises BP within minutes — Class I recommendation per ACC/AHA/HRS [4]
- Salt intake: Increase to 2–3 g sodium/day (or 6–10 g NaCl/day) unless contraindicated by heart failure or severe hypertension [1][3]
- Fluid intake: Target 2–3 L/day of total fluid [3]
- Avoid large carbohydrate-heavy meals (worsen postprandial hypotension); smaller, more frequent meals preferred [5]
- Alcohol avoidance: Vasodilatory effect worsens OH [5]
- Caffeine (100–250 mg) 15–30 min before meals may help postprandial hypotension [3]
- Long-term: Sustained adequate hydration and salt intake are foundational to management [3]
5. Review of Systems
- Cardiovascular: Palpitations, chest pain, exertional dyspnea (rule out cardiac syncope)
- Neurologic: Tremor, rigidity, gait instability (Parkinson disease/synucleinopathy), peripheral neuropathy symptoms (numbness, tingling) [5]
- GI: Nausea, early satiety, constipation, gastroparesis (autonomic neuropathy); weight loss and GI symptoms (consider amyloidosis) [3]
- GU: Urinary retention, incontinence, erectile dysfunction (autonomic dysfunction markers) [5]
- Endocrine: Polyuria, polydipsia (diabetes), fatigue and weight loss (adrenal insufficiency) [3]
- Hematologic: Melena, hematochezia, heavy menses (anemia/blood loss)
- Psychiatric: Anxiety, hyperventilation (psychogenic pseudosyncope)
6. Collateral History and Family History
- Witness account: Duration of LOC, abnormal movements (myoclonic jerks vs. seizure), skin color (pallor), speed of recovery [1]
- Family history: Sudden cardiac death, Brugada syndrome, hypertrophic cardiomyopathy, long QT syndrome [1][6]
- Hereditary conditions: Familial amyloidosis (transthyretin), hereditary sensory-autonomic neuropathies [3]
- Social context: Living alone (fall risk), driving (safety implications), occupation (heights, machinery), alcohol use
7. Risk Factors
- Age >60–70 years (age-related baroreflex impairment, reduced plasma volume conservation) [2-3]
- Polypharmacy (especially ≥4 medications) [3]
- Neurodegenerative disease: Parkinson disease, multiple system atrophy, dementia with Lewy bodies [5]
- Diabetes mellitus (autonomic neuropathy) [8]
- Deconditioning/prolonged bed rest [5]
- Dehydration from any cause (vomiting, diarrhea, poor intake, diuretics)
- Chronic kidney disease, adrenal insufficiency [3]
- Frailty and sarcopenia in older adults [3]
- Supine hypertension (coexists in ~50% of patients with nOH, complicates management) [9]
8. Differential Diagnosis
- Vasovagal (reflex) syncope: Triggered by emotional stress, pain, prolonged standing; prodrome of warmth, nausea, diaphoresis; typically younger patients [1]
- Cardiac syncope (cannot miss): Arrhythmia (VT, bradycardia, heart block), aortic stenosis, HCM, PE — syncope during exertion, while supine, or without prodrome [1]
- Postural orthostatic tachycardia syndrome (POTS): HR increase ≥30 bpm on standing without significant BP drop; predominantly younger women [5]
- Carotid sinus hypersensitivity: Older adults, triggered by head turning or tight collars [1]
- Seizure: Tonic-clonic activity, tongue biting, prolonged postictal confusion, urinary incontinence
- Hypoglycemia: Diaphoresis, tremor, confusion; check glucose
- Pulmonary embolism: Tachycardia, hypoxia, pleuritic chest pain, risk factors for VTE [1]
- GI hemorrhage: Melena, hematemesis, tachycardia, anemia [1]
- Psychogenic pseudosyncope: Prolonged episodes, eyes closed, no hemodynamic changes, frequent recurrence
Distinguishing features of orthostatic syncope: Consistent positional trigger, reproducible with standing, prodrome of lightheadedness/visual dimming, rapid recovery on lying down, positive orthostatic vitals. [1][5]
9. Past Medical History
- Prior syncopal episodes and their evaluation
- Parkinson disease, multiple system atrophy, or other synucleinopathies [5]
- Diabetes mellitus (duration, neuropathy status) [8]
- Hypertension and current antihypertensive regimen
- Heart failure, coronary artery disease, valvular disease
- Chronic kidney disease, adrenal insufficiency
- Prior head/neck surgery or radiation (baroreflex failure) [3]
- Amyloidosis (cardiac or peripheral neuropathy) [3]
- History of falls and fall-related injuries
10. Physical Exam
- Orthostatic vitals (gold standard bedside test): Measure BP and HR after 5 minutes supine, then at 1 and 3 minutes of standing. A drop of ≥20/10 mmHg is diagnostic. The active stand test is most sensitive when performed in the morning. [1][3]
- ΔHR/ΔSBP ratio: A ratio <0.5 at 3 minutes of standing suggests neurogenic OH (91% sensitivity, 88% specificity) [3][10]
- Cardiac exam: Murmurs (aortic stenosis, HCM), irregular rhythm, JVD, peripheral edema
- Neurologic exam: Parkinsonism (tremor, rigidity, bradykinesia), peripheral neuropathy (stocking-glove sensory loss), gait abnormalities [10]
- Volume status: Mucous membranes, skin turgor, capillary refill
- Rectal exam: If GI bleed suspected (occult blood)
- Skin: Pallor (anemia), signs of dehydration
11. Lab Studies
Recommended initial labs: [3][9]
- CBC: Anemia, infection
- BMP: Electrolytes, glucose, renal function, dehydration
- ECG: Arrhythmia, conduction disease (see ECG section)
- TSH: Thyroid dysfunction [9]
- Screen for supine hypertension: Affects ~50% of nOH patients and changes management [9]
Situational labs:
- Troponin / BNP: If cardiac etiology suspected [11]
- Hemoglobin / stool guaiac: If GI bleed suspected [1]
- Glucose: If hypoglycemia suspected
- hCG: Women of childbearing age [1]
- Cortisol: If adrenal insufficiency suspected [3]
- Vitamin B12: If peripheral neuropathy present [3]
- Plasma norepinephrine (supine and standing): Helps localize neurogenic lesion in specialized settings [10]
12. Imaging
- First-line: No routine imaging is indicated for clear orthostatic syncope [1][6]
- Echocardiography: Only if structural heart disease suspected (murmur, abnormal ECG, elevated BNP) — ACR recommends if clinical suspicion of cardiac etiology [1][6]
- CT head: Only if head trauma from fall or suspicion of intracranial pathology [1]
- CT angiography chest: If PE suspected [1]
- Neuroimaging (MRI brain): Only if focal neurologic findings suggest stroke or structural lesion [1]
- Imaging is unnecessary in straightforward orthostatic syncope with a clear positional trigger and positive orthostatic vitals [6]
13. Special Tests
- Active Stand Test (AST): Primary diagnostic test; most sensitive in the morning [3]
- ΔHR/ΔSBP ratio <0.5: Bedside test to distinguish neurogenic from non-neurogenic OH [3][10]
- Canadian Syncope Risk Score: Most accurate validated tool for 30-day risk stratification; components include ECG findings, physician diagnosis, vasovagal predisposition, heart disease history, SBP, and troponin [1][11]
- Head-up tilt table test: When bedside testing is inconclusive despite high clinical suspicion; also useful for differentiating from POTS or psychogenic pseudosyncope [1][3]
- Ambulatory BP monitoring: Documents OH frequency, postprandial hypotension, and nocturnal hypertension in daily life [5]
- Carotid sinus massage: For patients >40 years with unexplained syncope compatible with reflex mechanism [1]
- Autonomic function testing: Valsalva maneuver, deep breathing, sudomotor testing — for suspected neurogenic OH [10]
14. ECG
- Indicated in all patients presenting with syncope [1]
- Rule out cardiac causes: AV block (Mobitz II, complete heart block), bundle branch block, prolonged QTc, Brugada pattern, pre-excitation (WPW), ventricular arrhythmias, ischemic changes [12]
- Sinus tachycardia may be present in non-neurogenic OH (appropriate compensatory response to hypotension)
- Absence of compensatory tachycardia on standing suggests neurogenic OH or chronotropic incompetence [1]
- Dangerous patterns to recognize: New ST changes, wide QRS, Mobitz II or 3rd-degree AV block, nonsinus rhythm, left axis deviation [12]
- Prolonged monitoring (Holter, event recorder, implantable loop recorder): Reserved for recurrent unexplained syncope when arrhythmia is suspected [1]
15. Assessment
Orthostatic syncope is confirmed when:
- The clinical history is consistent with a positional trigger
- Orthostatic vitals demonstrate ≥20/10 mmHg BP drop on standing
- Cardiac red flags are absent [1][5]
Severity stratification:
- Mild: Infrequent presyncope, no falls or injuries, identifiable reversible cause (medication, dehydration)
- Moderate: Recurrent syncope, functional limitation, requires medication adjustment
- Severe: Frequent syncope with falls/injuries, neurogenic etiology, refractory to nonpharmacologic measures [5]
Key distinction — neurogenic vs. non-neurogenic: [3][10]
- Neurogenic OH (ΔHR/ΔSBP <0.5): Blunted heart rate response; associated with Parkinson disease, MSA, pure autonomic failure, diabetic autonomic neuropathy. Often coexists with supine hypertension. Worse prognosis, may herald neurodegenerative disease.
- Non-neurogenic OH: Appropriate tachycardic response; caused by volume depletion, medications, deconditioning. Generally reversible.
Complications: Fall-related injuries (hip fracture, subdural hematoma), reduced mobility and independence, increased mortality in older adults. [3]
16. Treatment Plan
Initial stabilization (ED):
- Place supine with legs elevated
- IV fluid bolus (NS or LR) if dehydrated or hypovolemic
- Hold/reduce offending medications
- Treat underlying cause (e.g., blood transfusion for GI bleed, glucose for hypoglycemia)
Nonpharmacologic measures (first-line for all patients): [1][3]
- Medication review and deprescribing of offending agents
- Bolus water drinking: 500 mL rapidly — raises BP within minutes (Class I, ACC/AHA) [4]
- Increased salt intake: 2–3 g Na+/day (unless HF)
- Increased fluid intake: 2–3 L/day
- Physical counterpressure maneuvers: Leg crossing, squatting, calf muscle pumping before/during standing
- Compression garments: Waist-high stockings (30–40 mmHg) or abdominal binders
- Elevate head of bed 10–15 degrees (reduces overnight natriuresis and supine hypertension) [1]
- Avoid triggers: Rapid postural changes, prolonged standing, hot environments, large meals, alcohol
- Graduated exercise program to combat deconditioning
Pharmacologic treatment (when nonpharmacologic measures insufficient): [3-5]
- First-line: Midodrine (2.5–10 mg TID) — only FDA-approved drug for both nOH and non-nOH
- First-line for nOH with supine HTN: Droxidopa (100–600 mg BID-TID) — lower risk of supine hypertension
- Second-line: Fludrocortisone (0.05–0.2 mg daily) — avoid in HF; monitor electrolytes at 1 week
- If coexisting hypertension: Pyridostigmine (30–60 mg TID) — selectively raises upright BP without worsening supine HTN [7]
- Postprandial hypotension: Acarbose (50–100 mg before meals) or caffeine (100–250 mg before meals) [3]
Supine hypertension management (coexists in ~50% of nOH): [8-9]
- Elevate head of bed
- Short-acting agents at bedtime: clonidine, isradipine, or atenolol
17. Disposition
Discharge criteria (most orthostatic syncope patients can be safely discharged): [1][13]
- Clear orthostatic etiology identified (positive orthostatic vitals + consistent history)
- No cardiac red flags (normal ECG, no structural heart disease, no exertional syncope)
- Hemodynamically stable after rehydration
- Able to ambulate safely
- Reversible cause identified and addressed (medication adjustment, rehydration)
- Reliable follow-up arranged
Admission/observation criteria: [1][13]
- Orthostatic syncope with serious injury from fall (e.g., hip fracture, head trauma, intracranial hemorrhage)
- Persistent symptomatic hypotension despite IV fluids
- Concern for concurrent cardiac etiology that has not been excluded
- Significant underlying condition requiring treatment (GI bleed, severe anemia, sepsis)
- Elderly patients with frailty, recurrent falls, and inability to safely ambulate
- New neurologic findings suggesting underlying neurodegenerative disease requiring workup
Specialist consultation triggers:
- Suspected neurogenic OH → Neurology/autonomic specialist [5][10]
- Suspected cardiac etiology → Cardiology
- Refractory OH despite medication optimization → Autonomic/dysautonomia center [3]
18. Follow Up / Return Precautions
Follow-up timing:
- PCP follow-up within 1–2 weeks for medication reconciliation and repeat orthostatic vitals
- Earlier if medication changes were made
- Neurology referral if neurogenic OH suspected or new parkinsonian features identified
Return precautions — advise patients to return immediately for:
- Recurrent syncope, especially without positional trigger
- Chest pain, palpitations, or shortness of breath
- Focal weakness, speech difficulty, or vision loss
- Significant head injury or fall with inability to ambulate
- Bloody or black stools
- Persistent dizziness despite adequate hydration
Patient counseling points: [1][3]
- Rise slowly from lying/sitting (sit at bedside for 1–2 minutes before standing)
- Avoid prolonged standing, hot showers/baths, and large meals
- Stay well hydrated; increase salt intake as directed
- Perform counterpressure maneuvers (leg crossing, squatting) when feeling lightheaded
- Avoid driving until symptoms are controlled
- Wear compression stockings as prescribed
Expected recovery course: Non-neurogenic OH (medication-induced, dehydration) often resolves with correction of the underlying cause. Neurogenic OH is typically chronic and progressive, requiring ongoing management and periodic reassessment. [3][5]
The following algorithm provides a comprehensive diagnostic and treatment approach to orthostatic hypotension:
References
1. Syncope: Evaluation and Differential Diagnosis. — Bayard M, Gerayli F, Holt J. American Family Physician. 2023.
2. Syncope: Evaluation and Differential Diagnosis. — Bayard M, Gerayli F, Holt J. American Family Physician. 2023.
3. Syncope: Evaluation and Differential Diagnosis. — Bayard M, Gerayli F, Holt J. American Family Physician. 2023.
4. Best Practices Guidelines Geriatric Trauma Management. — Alicia Mangram MD FACS, Jessica M. Berdeja MD, Christine S. Cocanour MD FACS FCCM, et al American College of Surgeons (2023). 2023.
5. Best Practices Guidelines Geriatric Trauma Management. — Alicia Mangram MD FACS, Jessica M. Berdeja MD, Christine S. Cocanour MD FACS FCCM, et al American College of Surgeons (2023). 2023.
6. Management of Orthostatic Hypotension. — Moloney D, Youssef A, Okamoto LE. JAMA Internal Medicine. 2026.
7. Management of Orthostatic Hypotension. — Moloney D, Youssef A, Okamoto LE. JAMA Internal Medicine. 2026.
8. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Shen WK, Sheldon RS, Benditt DG, et al. Journal of the American College of Cardiology. 2017.
9. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Shen WK, Sheldon RS, Benditt DG, et al. Journal of the American College of Cardiology. 2017.
10. Diagnosis and Treatment of Orthostatic Hypotension. — Wieling W, Kaufmann H, Claydon VE, et al. The Lancet. Neurology. 2022.
11. Diagnosis and Treatment of Orthostatic Hypotension. — Wieling W, Kaufmann H, Claydon VE, et al. The Lancet. Neurology. 2022.
12. ACR Appropriateness Criteria® Syncope. — Kligerman SJ, Bykowski J, Hurwitz Koweek LM, et al. Journal of the American College of Radiology : JACR. 2021.
13. ACR Appropriateness Criteria® Syncope. — Kligerman SJ, Bykowski J, Hurwitz Koweek LM, et al. Journal of the American College of Radiology : JACR. 2021.
14. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association. — Juraschek SP, Cortez MM, Flack JM, et al. Hypertension. 2024.
15. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association. — Juraschek SP, Cortez MM, Flack JM, et al. Hypertension. 2024.
16. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. — American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care. 2026.
17. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. — American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care. 2026.
18. Orthostatic Hypotension: A Practical Approach. — Kim MJ, Farrell J. American Family Physician. 2022.
19. Orthostatic Hypotension: A Practical Approach. — Kim MJ, Farrell J. American Family Physician. 2022.
20. Baroreflex Dysfunction. — Kaufmann H, Norcliffe-Kaufmann L, Palma JA. The New England Journal of Medicine. 2020.
21. Baroreflex Dysfunction. — Kaufmann H, Norcliffe-Kaufmann L, Palma JA. The New England Journal of Medicine. 2020.
22. Canadian Syncope Risk Score: A Validated Risk Stratification Tool. — Meisenheimer ES, Rogers TS, Saguil A. American Family Physician. 2021.
23. Canadian Syncope Risk Score: A Validated Risk Stratification Tool. — Meisenheimer ES, Rogers TS, Saguil A. American Family Physician. 2021.
24. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
25. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
26. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Writing Committee Members, Shen WK, Sheldon RS, et al. Heart Rhythm. 2017.
27. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Writing Committee Members, Shen WK, Sheldon RS, et al. Heart Rhythm. 2017.